跳至主要内容
临床试验/CTRI/2024/02/062963
CTRI/2024/02/062963
尚未招募
不适用

To evaluate and compare the in-vivo safety and efficacy of three skin care formulations versus Untreated control in terms of the moisturization effect on healthy human subjects.

Dabur India Ltd.1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2024年2月25日最近更新:

概览

阶段
不适用
状态
尚未招募
入组人数
36
试验地点
1
主要终点
Improvement in skin Moisturization

概览

简要总结

OBJECTIVE

The objective of this study will be to evaluate and compare the in-vivo safety and efficacy of three Skin Care Formulations versus Untreated control in terms of the Moisturizing Effect on healthy human subjects

The evaluation is performed using: Subject Self Evaluation (SSE), Dermatological Evaluation: Cosmetic Acceptability, Corneometry

POPULATION: 33 (16/17 females & 17/16 males) subjects are selected for this study.

The subjects selected for this study are healthy females and males aged between 18 and 65 years, having dry skin on forearms.

 STUDY DURATION: 72 Hours following the application of the product.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….) 2)Subject having dry skin on forearms.

排除标准

  • For female: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months.Having refused to give her assent by signing the consent form.
  • Taking part in another study liable to interfere with this study.
  • Being known diabetic case 4)Known asthma case 5)Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis) 6)Being known thyroid case 7)Being epileptic.
  • Following a chronic medicinal treatment comprising any of the following product: aspirin-based product, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes or corticosteroid by any route (the only medication permitted is paracetamol) 9)Known case of hypersensitivity.
  • Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic product.
  • Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.
  • Having changed their cosmetic habits except those required by the protocol in the 14 days preceding the start of the study on the studied anatomic unit.
  • Having applied a cosmetic product (included make-up) on the studied areas 48 hours prior study.

结局指标

主要结局

Improvement in skin Moisturization

时间窗: Baseline, 30 minutes, 48 hours and 72 hours

次要结局

未报告次要终点

研究者

申办方类型
Other [fmcg]
责任方
Principal Investigator
主要研究者

Dr Raji Patil

MASCOT-SPINCONTROL India Pvt. Ltd.

研究点 (1)

Loading locations...

相似试验